You searched for "interview"

1704 results found

DRIL after macular oedema treatment in BRVO

The authors report the analysis of a single-site, retrospective, cross-sectional study to evaluate the association between disorganisation of the retinal inner layers (DRIL) and visual acuity (VA) after anti-VEGF treatment for macular oedema (MO) due to branch retinal vein occlusion...

Planes, trams, and auditoriums: Beware predatory conferencing

Predatory open-access journals and predatory conferences are considered the two main areas of predatory infiltration in academic medicine that are of growing concern [1–7]. Unsolicited publishing requests from potentially predatory publishers occur frequently among faculty in ophthalmology [8]. Predatory conferencing...

Zeiss field machines, public Wi-Fi risks and IoT scanning

End of support for old field machines Zeiss have recently announced that they are withdrawing support contracts for many of their older 7 series Humphrey Field Analysers (HFAs) in November 2017. They have confirmed maintenance contracts can continue, but repairs...

Understanding spaceflight-associated neuro-ocular syndrome (SANS): what do we know?

Introduction Formerly known as visual impairment and intracranial pressure syndrome (VIIP), space-related neuro-ocular syndrome (SANS) is defined by a collection of ophthalmic and neurological findings in astronauts after long-term spaceflight [1]. Changes in the eyeball, such as hyperopic shift, during...

‘Agenda-setting’ BCLA Clinical Conference to shape the future of contact lens practice around the world

The global eye care professional network’s “unquenchable thirst for learning” ensured the success of the first in-person BCLA Clinical Conference & Exhibition in four years.

High dose (2.5mg) bevacizumab for postradiation cystoid macular oedema

The authors present a retrospective, interventional case series investigating the efficacy of high dose (2.5mg/0.1ml) intravitreal bevacizumab in the treatment of persistent postradiation (Iodine-125 plaque brachytherapy for uveal melanoma) cystoid macular oedema (CME). Persistent CME was defined as increased or...

Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration

This is a sub-group study of double masked review of patients randomised to different dosages and treatment frequency compared between aflibercept and ranibizumab treatment. This is to evaluate the efficacy and safety of intravitreal aflibercept (IVT-AFL) in Japanese patients with...

Highlights from The RCOphth Annual Congress 2023

Check in here for live updates and media from the RCOphth Annual Congress 2023 being held in Birmingham's ICC between 22-25 May.

Thank you, Baljean Dhillon. Welcome onboard, Peter Cackett.

As our Co-editor of over 11 years, Baljean Dhillon, passes the torch, Peter Cackett steps up to take on the role.

RNIB working with games studios to make VR more accessible

Abertay University and RNIB launch toolkit to make extended reality experiences more accessible for blind and partially sighted people. The new guidance launched in December 2025 will support accessible design in games and immersive experiences for blind and partially sighted...

Martial arts mum fights for inclusive employment

A visually impaired mum in West Lothian is calling for more accessible and inclusive employment for people with sight loss. Amanda Whitfield (35) recently won medals alongside her five-year-old daughter in mixed martial arts, after taking part in local family...

100% Ophthalmology Programme Insights

We spoke to some of the Eye News family about their upcoming presentations at 100% Opthalmology, 24–26 February 2024, ExCeL London, UK.